Skip to content
Subscribe

We Cannot Put a Price on a Loved One's Life – Vote Yes on Proposition 14

We Cannot Put a Price on a Loved One's Life – Vote Yes on Proposition 14
Published:

This is an independent opinion. Have one of your own? Email it to hoa@ivn.us

Reality is chronic diseases, illnesses and conditions impact each and every one of us. The harsh, but unfortunate truth is not if, but when you or someone you love will be impacted by that fate. For my family, that day became a reality when our newborn daughter was diagnosed with a fatal immunodeficiency disease that would only give her a couple of years to live.

In 2012, when my daughter Evangelina, “Evie,” was just six weeks old, she was diagnosed with severe combined immunodeficiency (SCID). More commonly known as “bubble baby” disease, the rare genetic disorder left her at risk of death from any infection, even a diaper rash or the common cold. Born alongside a healthy twin, we were told Evie would likely not make it to her second birthday.

Find More Election 2020 Coverage Here

However, thanks to Proposition 71 in 2004, California voter’s initial investment in stem cell research and the California Institute for Regenerative Medicine, a groundbreaking treatment was discovered at the University of California Los Angeles that saved my daughter’s life and 49 other babies born with the same rare disease – giving them all functioning immune systems and a second chance to live a long, healthy life.

This November, Californians have an opportunity to keep us on track of continuing to find treatments and cures for the dozens of deadly diseases and illnesses that affect millions every year. With a yes vote on Proposition 14, we have the opportunity to continue providing research and therapy development for more than 75 chronic diseases and conditions, including cancer, diabetes, Alzheimer’s, Parkinson’s, heart disease, SCID and COVID-19.

Evie. Courtesy photo

‍
Since 2004, CIRM has made incredible progress, which has led to more than 90 clinical trials, two FDA-approved cancer treatments and nine new treatments that have earned FDA fast-track status. While most of the 90-plus clinical trials are still underway, many lives have already been saved or improved. We have helped patients with Type I Diabetes start to produce their own insulin, blind patients begin to regain their eyesight and quadriplegics recover upper body function.

The reality is California is the only state with the infrastructure and intellectual capital to advance these clinical trials and medical discoveries through to FDA-approved treatments. There is no other entity — private or public — that can take it from here and to the scale that we as a state can. We’ve seen time and time again instances where the federal government has been inconsistent when it comes to funding breakthrough stem cell research.

If Californians do not pass Proposition 14, the hope of discovering more cures like the one that saved Evie’s life will be gone. Investing in the health of our loved ones, and ourselves, is one of the most important things we can do today. Proposition 14 will work to end this suffering for the millions of Californians and their families impacted by chronic diseases and conditions – how can we not support that?

I’ve seen firsthand the possible treatments and lifesaving cures that Proposition 14 could bring to your life or the life of someone you love. So, join me and the growing coalition of more than 100 patient advocacy organizations, hundreds of leading scientists and physicians, Nobel Prize winners, senior elected officials and leaders, the University of California and many, many more in voting yes on Proposition 14.

Adhere to the IVN etiquette

By posting a comment, you agree to adhere to our etiquette rules: No partisan attacks, no personal attacks, substantiate your sources, no self-promotion.

Contact IVN

Questions about this article or our coverage? Send us a message. A free IVN member account is required.

Message sent

Thanks, we’ll review it and get back to you if needed.

Message not sent

Sorry, something went wrong. Please try again.

Sign in to send a message

Messages are tied to your IVN member account. Signing in is free and takes a few seconds.

Contact IVN

Questions about this article or our coverage? Send us a message. A free IVN member account is required.

Message sent

Thanks, we’ll review it and get back to you if needed.

Message not sent

Sorry, something went wrong. Please try again.

Sign in to send a message

Messages are tied to your IVN member account. Signing in is free and takes a few seconds.

Republish this article

Republishing guidelines

Republish IVN articles for free. Independent Voter News articles may be republished online or in print under a Creative Commons BY-NC-ND 4.0 license, on these terms:

  1. Credit the author and IVN. Keep the byline ("By Author Name, Independent Voter News") and the attribution note at the end, which links to the original.
  2. Keep the meaning. You may update time and place references and apply your house style. You may trim for length, as long as the cuts don't change the meaning or misrepresent the author. Keep the headline. Mark any additions as your own (for example "Additional reporting by ...").
  3. Translations are welcome. Translate faithfully, add "Translated from English by [your outlet]", and tell us at editor@ivn.us.
  4. Keep the links, including the link to the original article.
  5. Keep the tracking image. The HTML includes a 1-pixel image that counts readers on your page. It collects no personal information.
  6. Photos and illustrations. Images credited to IVN may be used with this article only. Images credited to others (AP, Getty, Unsplash, Wikimedia and so on) stay under their owners' terms. Secure the rights or switch "Include images" off.
  7. Don't sell it. You can't sell our articles or sell ads specifically against them. Your normal site advertising is fine.
  8. No implied endorsement. Don't suggest that IVN or the author endorses you, your candidates or your causes, or that donations to you support IVN.
  9. Keep labels. Opinion or analysis pieces keep that label.
  10. Point search engines to the original. Where your CMS allows, set the canonical URL to the original IVN article.
  11. No bulk or automated republishing, and don't submit our articles to aggregators (Apple News, Google News, MSN) as your own.
  12. Corrections and removals. Update your copy when we correct it, and remove it promptly if we ask. We'll contact you at the email you give us.
  13. Questions or print republication: editor@ivn.us.

IVN staff: fill in who you're inviting above, then create the invite.

Preparing the article

We Cannot Put a Price on a Loved One's Life – Vote Yes on Proposition 14

Choose a format
  • HTML
  • Email HTML
  • Markdown
  • Formatted (.docx)
  • Plain text
  • WordPress blocks
  • PDF
Choose a platform

Photos credited to others need their owners' permission.

To for

Republishing somewhere else? Questions? editor@ivn.us